Observational studyFrontiers in immunology2026
Real-world insights into incidence and risk factors of thyroid dysfunction following immune checkpoint inhibitor therapy.
Lingyan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.